NCT05921591View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of IRL201104 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 26, 2023

Primary Completion Date

September 12, 2023

Study Completion Date

September 12, 2023

Conditions
Healthy Volunteer
Interventions
DRUG

IRL201104

Lyophilised powder for reconstitution for IV dosing

DRUG

Placebo

Matching placebo for IRL201104

Trial Locations (1)

90630

Revolo Phase I site, Los Angeles

Sponsors
All Listed Sponsors
lead

Revolo Biotherapeutics

INDUSTRY

NCT05921591 - Safety, Tolerability, and Pharmacokinetics of IRL201104 in Healthy Volunteers | Biotech Hunter | Biotech Hunter